Engrave Wealth Partners’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$57.2K Hold
2,120
0.02% 80
2023
Q3
$64.4K Hold
2,120
0.02% 70
2023
Q2
$134K Hold
2,120
0.04% 67
2023
Q1
$178K Hold
2,120
0.06% 70
2022
Q4
$502K Buy
2,120
+143
+7% +$27.5K 0.17% 42
2022
Q3
$445K Hold
1,977
0.21% 34
2022
Q2
$956K Buy
+1,977
New +$2.33M 0.42% 22

Other funds holding NUTX

Engrave Wealth Partners's NUTX Position: Q4 2023 in Review

Engrave Wealth Partners held its Nutex Health (NUTX) position steady in Q4 2023 at 2,120 shares worth $57.2K. The position accounts for 0.02% of the portfolio, ranked #80.

Engrave Wealth Partners first reported a position in NUTX in Q2 2022 and has held it in 7 quarters since. The position peaked at $956K in Q2 2022. 49 funds tracked by Wall St. Rank hold NUTX as of Q4 2023.

  • Engrave Wealth Partners held 2,120 shares of Nutex Health worth $57.2K as of Q4 2023.
  • Engrave Wealth Partners left its Nutex Health share count unchanged in Q4 2023.
  • Nutex Health made up 0.02% of Engrave Wealth Partners's portfolio in Q4 2023, its #80 holding.
  • Engrave Wealth Partners first reported a position in Nutex Health in Q2 2022 and has held it in 7 quarters since.
  • Engrave Wealth Partners's Nutex Health position peaked at $956K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Nutex Health as of Q4 2023.

Based on Engrave Wealth Partners's 13F filing for Q4 2023, filed 16 Jan 2024.